期刊文献+

2005—2014年华中科技大学同济医学院附属同济医院细菌耐药性监测 被引量:20

Surveillance of antimicrobial resistance in clinical isolates from Tongji Hospital during the period from 2005 to 2014
下载PDF
导出
摘要 目的分析武汉同济医院2005年1月—2014年12月临床分离细菌分布及其对常用抗菌药物耐药性变迁。方法采用纸片扩散法(K-B法)进行抗菌药物敏感性试验,E试验检测青霉素和头孢曲松对肺炎链球菌及万古霉素对葡萄球菌属的MIC。结果 10年间共获得非重复临床分离菌株56 205株,其中革兰阴性菌38 628株,占68.7%,革兰阳性菌17 577株,占31.3%。排名前5位的分离菌分别为大肠埃希菌、不动杆菌属、金黄色葡萄球菌(金葡菌)、克雷伯菌属和铜绿假单胞菌。10年间不动杆菌属分离率呈现逐年升高趋势,凝固酶阴性葡萄球菌呈现逐年下降趋势。甲氧西林耐药金葡菌(MRSA)和甲氧西林耐药凝固酶阴性葡萄球菌(MRCNS)的平均检出率分别为64.7%和79.8%,有逐年增高趋势。粪肠球菌在10年间维持对氨苄西林、青霉素、万古霉素、替考拉宁、利奈唑胺、高浓度庆大霉素、左氧氟沙星较高敏感率,而屎肠球菌对多种抗菌药物耐药率高,并呈现耐药率增高趋势,仅对万古霉素、替考拉宁、利奈唑胺耐药率较低。10年来,大肠埃希菌、克雷伯菌属(肺炎克雷伯菌和产酸克雷伯菌)、奇异变形杆菌中产ESBL菌株的比例呈逐年增长趋势,产ESBL菌株对检测抗菌药物敏感率均低于非产ESBL菌株。碳青霉烯类耐药的肠杆菌科细菌(CRE)近年增长显著。不发酵糖革兰阴性杆菌中不动杆菌属分离率逐渐增加并成为医院感染最常见的菌种,不动杆菌属对多种检测抗菌药物耐药率呈逐年上升趋势,而铜绿假单胞菌对测试抗菌药物仍保持较高的敏感率。结论细菌耐药性监测10年间,多重耐药菌分离率呈上升趋势,且多数临床分离菌也呈增长趋势,给临床治疗带来一定挑战。 Objective To investigate the distribution and changing antimicrobial resistance of bacterial strains isolated from patients in Tongii Hospitial during the period from January 2005 through December 2014. Methods Antimicrobial susceptibility was tested by Kirby-Bauer method. The minimum inhibitory concentrations of penicillin and ceftriaxone against Streptococcus pneumoniae and vancomycin against Staphyloccus spp. were determined by E-test. Results A total of 56 205 strains were isolated during the 10-year period, including gram-negative bacteria (38 628, 68.7%) and gram-positive bacteria (17 577, 31.3%).The top five pathogenic bacterial species were Escherichia coli, Acinetobacter spp, S. aureus, Kelbsiella spp. and P. aeruginosa. The proportion of Acinetobacter isolates increased year by year during the lO-year period, but the proportion of coagulase-negative Staphylococcus was on decline. The average prevalence of methicillin resistant strains in S.aureus and coagulase-negative Staphylococcus was 64.7% and 79.8%, respectively with an increasing trend during the 10-year period. The Enterococcus faecalis strains still showed high susceptibility rate to ampicillin, penicillin, vancomycin, teicoplanin, linezolid, gentamicin (high level). But the E. faeeium isolates were highly resistant to most antimicrobial agents except vancomycin, teicoplanin, and linezolid. Over the 10-year period, the prevalencce of ESBLs-producing strains in Escherichia coli, Klebsiella spp. (K. pneumoniae and K. oxytoca), and Proteus mirabilis showed an increasing trend. The ESBLs-producing strains were always more resistant than the corresponding non-ESBLs-producing strains. The growth of carbapenem-resistant Enterobacteriaceae was remarkable in the last two years. The number ofAcinetobacter spp. strains gradually increased in recent years and became one of the most common pathogens of nosocomial infection. The resistance rates of Acinetobacter spp. to multiple antimicrobial agents were on the rise, while the susceptibility profile ofP. aeruginosa remained stable over years. Conclusions Surveillance of bacterial resistance in hospitals across China during the 2005-2014 period showed that the prevalence of multi-drug resistant bacteria was on the rise. The increasing resistance of common pathogens has become a maior challenge to clinical nractiee.
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2016年第2期165-178,共14页 Chinese Journal of Infection and Chemotherapy
关键词 细菌耐药性监测 抗菌药物 多重耐药菌 bacterial resistance surveillance antimicrobial agent multi-drug resistant bacterium
  • 相关文献

参考文献12

  • 1Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S].Twenty- fourth informational supplement,2014,M100-S24.
  • 2BELL JM,PATON JC,TURNIDGE J.Emergence of vancomycin-resistant enterococci in Australia:phenotypic and genotypic characteristics of isolates[J].J Clin Microbiol,1998,36(8):2187-2190.
  • 3ZHU X,LIU C,GAO S,et al.Vancomycin intermediate- resistant Staphylococcus aureus (VISA) isolated from a patient who never received vancomycin treatment[J].Int J Infect Dis,2015,33:185-190.
  • 4胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:622
  • 5张小江,杨启文,孙宏莉,王贺,王瑶,谢秀丽,原英,窦红涛,宋红梅,王澎,朱任媛,赵颖,刘娟,刘文静,郭莉娜,徐英春.2005—2010年北京协和医院细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):330-339. 被引量:22
  • 6药小萍,吴学勇,翁丽贞,袁剑庆.耐甲氧西林金黄色葡萄球菌感染的流行病学及耐药性研究[J].中华医院感染学杂志,2011,21(16):3483-3485. 被引量:10
  • 7刘彩林,陈中举,孙自镛,曹伟,冯羡菊,王山梅,曾吉,邹明祥,汪明,孙明月,侯红艳.中南地区金黄色葡萄球菌流行病学及耐药性研究[J].中华微生物学和免疫学杂志,2013,33(6):410-415. 被引量:3
  • 8DAIKOS GL,TSAOUSI S,TZOUVELEKIS LS,et al.Carbapenemase-producing Klebsiella pneumoniae bloodstream infections:lowering mortality by antibiotic combination schemes and the role of carbapenems[J].Antimicrob Agents Chemother,2014,58(4):2322-2328.
  • 9VAN DUIN D,KAYE KS,NEUNER EA,et al.Carbapenem- resistant Enterobacteriaceae ; a review of treatment and outcomes[J].Diagn Microbiol Infect Dis,2013,75(2); 115-120.
  • 10TASCINI C,TAGLIAFERRI E,GIANI T,et al.Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae[J].Antimicrob Agents Chemother,2013,57(8):3990-3993.

二级参考文献65

  • 1刘文静,张小江,杨文航,谢秀丽,王贺,杨启文,徐英春,陈民钧.2008年北京协和医院细菌耐药性监测结果分析[J].中国感染与化疗杂志,2010,10(4):290-296. 被引量:20
  • 2王臻,童朝辉,徐莉莉,王辰,张洪玉,杜小玲,王清涛.万古霉素治疗下呼吸道耐甲氧西林葡萄球菌感染的疗效观察[J].中华医院感染学杂志,2004,14(12):1403-1405. 被引量:18
  • 3彭奕冰,项明洁,张健,季育华.随机扩增多态性DNA分型法在铜绿假单胞菌流行病学研究方面的应用[J].中华医院感染学杂志,2006,16(6):605-607. 被引量:4
  • 4Clinical and Laboratory Standards Institute (CLSI). Perform- ance standards for antimicrobial susceptibility testing [S]. M100-S20, 2010.
  • 5Zhanel GG, DeCorby M, Nichol KA, et al. Characterization of MRSA, VRE and ESBL producing E. coil in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN ICU) Study (2005 2006)[J]. Can J Infect Dis Med Microbiol, 2008, 19(3):243-249.
  • 6Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased suscep- tibility to carbapenems: results from large hospital based sur- veillance studies in China[J]. Antimicrob Agents Chemother. 2010, 54(1):573-577.
  • 7Cai JC, Zhou HW, Zhang R, et al. Emergence of Serratia marcescens, Klebsiella pneumoniae and Escherichia coli iso lates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC 2 in intensive care units of Chinese hospi- tal[J]. Antimicrob Agents Chemother, 2008, 52 (6): 2014- 2018.
  • 8Yuan Z, Tam VH. Polymyxin B: a new strategy for multi drug resistant Gram negative organisms[J]. Expert Opin In vest Drugs, 2008 I7(5): 661-668.
  • 9Bulik CC, Nicolau DP. In vivo efficacy of simulated human dosing regimens of prolonged infusion doripenem against car-bapenemase-producing Klebsiellapneumoniae[J]. Antimierob Agents Chemother, 2010, 54(10) :4112-4115.
  • 10Elemam A, Rahimian J, Doymaz M. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase- producing Klebsiella pneumoniae[J]. J Clin Microbiol, 2010, 48(10): 3558-3562.

共引文献664

同被引文献151

引证文献20

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部